2016 Q4 Form 10-K Financial Statement

#000109991022000217 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $146.7K
YoY Change -15.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $263.00
YoY Change -98.01%
% of Gross Profit
Operating Expenses $359.6K
YoY Change -56.75%
Operating Profit -$212.9K
YoY Change -67.64%
Interest Expense $335.1K
YoY Change 15.23%
% of Operating Profit
Other Income/Expense, Net $857.2K
YoY Change 67.07%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $644.3K
YoY Change -155.02%
Net Earnings / Revenue 439.09%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 214.6M shares 172.3M shares
Diluted Shares Outstanding 671.5M shares

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $21.41K $7.592K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $5.450K
Prepaid Expenses
Receivables $3.307K
Other Receivables
Total Short-Term Assets $26.86K $17.10K
YoY Change 57.1% -21.49%
LONG-TERM ASSETS
Property, Plant & Equipment $14.74K $15.00K
YoY Change -1.75% 809.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $14.74K $15.00K
YoY Change -1.75% 357.35%
TOTAL ASSETS
Total Short-Term Assets $26.86K $17.10K
Total Long-Term Assets $14.74K $15.00K
Total Assets $41.60K $32.10K
YoY Change 29.6% 28.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $167.9K $103.4K
YoY Change 62.28%
Accrued Expenses $2.088M $2.011M
YoY Change 3.84%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.382M $6.200M
YoY Change -13.2% 40959.96%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.382M $6.200M
Total Long-Term Liabilities
Total Liabilities $5.382M $6.200M
YoY Change -13.2% 40959.96%
SHAREHOLDERS EQUITY
Retained Earnings -$6.114M -$6.758M
YoY Change -9.53%
Common Stock $214.6K $123.1K
YoY Change 74.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.340M -$6.168M
YoY Change
Total Liabilities & Shareholders Equity $41.60K $32.10K
YoY Change 29.6% 28.1%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income $644.3K
YoY Change -155.02%
Depreciation, Depletion And Amortization $263.00
YoY Change -98.01%
Cash From Operating Activities -$268.2K
YoY Change 109.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $142.5K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $282.0K
YoY Change 127.3%
NET CHANGE
Cash From Operating Activities -$268.2K
Cash From Investing Activities
Cash From Financing Activities $282.0K
Net Change In Cash $13.82K
YoY Change -434.27%
FREE CASH FLOW
Cash From Operating Activities -$268.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
usd
CY2016 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2015 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2016 QBAN Merger With Amgentech And Recapitalization
MergerWithAmgentechAndRecapitalization
usd
CY2016 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7C
CY2016 dei Entity Address City Or Town
EntityAddressCityOrTown
Ormond Beach
CY2016 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2015 QBAN Merger With Amgentech And Recapitalization
MergerWithAmgentechAndRecapitalization
usd
CY2016 QBAN Transfer Insufficient Additional Paidincapital Balance To Retained Earnings
TransferInsufficientAdditionalPaidincapitalBalanceToRetainedEarnings
usd
CY2016 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32174
CY2016 QBAN Common Stock Issued For Merger And Recapitalization Net
CommonStockIssuedForMergerAndRecapitalizationNet
usd
CY2016 dei City Area Code
CityAreaCode
305
CY2015 QBAN Conversion Of Preferred B Shares To Common Shares
ConversionOfPreferredBSharesToCommonShares
usd
CY2015 QBAN Insufficient Additional Paidincapital Balance Transferred To Accumulated Deficit
InsufficientAdditionalPaidincapitalBalanceTransferredToAccumulatedDeficit
usd
CY2016 QBAN Preferred Shares Returned To Company
PreferredSharesReturnedToCompany
usd
CY2016 QBAN Conversion Of Preferred B To Common Shares
ConversionOfPreferredBToCommonShares
usd
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2016 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0546544
CY2016 dei Entity Address Address Line1
EntityAddressAddressLine1
454 S Yonge Street
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001427644
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016Q4 us-gaap Deposits
Deposits
usd
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2015Q4 us-gaap Inventory Net
InventoryNet
usd
CY2015 QBAN Recapitalization Telco Cuba1
RecapitalizationTelcoCuba1
usd
CY2016 QBAN Derivative Liabilities Recorded
DerivativeLiabilitiesRecorded
usd
CY2016 QBAN Gain Loss On Derivative Liabilities
GainLossOnDerivativeLiabilities
usd
CY2015 QBAN Gain Loss On Derivative Liabilities
GainLossOnDerivativeLiabilities
usd
CY2016 QBAN Debt Discount Attributable To Derivative Liabilities Recorded
DebtDiscountAttributableToDerivativeLiabilitiesRecorded
usd
CY2015 QBAN Debt Discount Attributable To Derivative Liabilities Recorded
DebtDiscountAttributableToDerivativeLiabilitiesRecorded
usd
CY2016 QBAN Derivative Liabilities Converted During Period
DerivativeLiabilitiesConvertedDuringPeriod
usd
CY2015 QBAN Derivative Liabilities Converted During Period
DerivativeLiabilitiesConvertedDuringPeriod
usd
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2016 QBAN Discount Upon Issuance Of New Notes
DiscountUponIssuanceOfNewNotes
usd
CY2016 QBAN Issuance Of Notes To Related Party
IssuanceOfNotesToRelatedParty
usd
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Document Annual Report
DocumentAnnualReport
true
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-11-30
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2016 dei Document Transition Report
DocumentTransitionReport
false
CY2016 dei Entity File Number
EntityFileNumber
000-53157
CY2016 dei Entity Registrant Name
EntityRegistrantName
Telco Cuba, Inc.
CY2016 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2016 dei Local Phone Number
LocalPhoneNumber
747-7647
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2016 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2016 dei Entity Small Business
EntitySmallBusiness
true
CY2016 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2016 dei Entity Shell Company
EntityShellCompany
false
CY2016Q4 dei Entity Public Float
EntityPublicFloat
107315 usd
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
214631231 shares
CY2016Q4 us-gaap Cash
Cash
21414 usd
CY2015Q4 us-gaap Cash
Cash
7592 usd
CY2015Q4 us-gaap Deposits
Deposits
6201 usd
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3307 usd
CY2016Q4 us-gaap Inventory Net
InventoryNet
5450 usd
CY2016Q4 us-gaap Assets Current
AssetsCurrent
26864 usd
CY2015Q4 us-gaap Assets Current
AssetsCurrent
17100 usd
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6686 usd
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6423 usd
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14738 usd
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15001 usd
CY2016Q4 us-gaap Assets
Assets
41602 usd
CY2015Q4 us-gaap Assets
Assets
32101 usd
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
167854 usd
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
103436 usd
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2088082 usd
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2010792 usd
CY2016Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
120577 usd
CY2015Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
132577 usd
CY2016Q4 QBAN Convertible Debentures Related Parties
ConvertibleDebenturesRelatedParties
15000 usd
CY2015Q4 QBAN Convertible Debentures Related Parties
ConvertibleDebenturesRelatedParties
1973 usd
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2236446 usd
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2233361 usd
CY2016Q4 QBAN Convertible Debenture
ConvertibleDebenture
621843 usd
CY2015Q4 QBAN Convertible Debenture
ConvertibleDebenture
393506 usd
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
132098 usd
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1324409 usd
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5381900 usd
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6200054 usd
CY2016Q4 us-gaap Liabilities
Liabilities
5381900 usd
CY2015Q4 us-gaap Liabilities
Liabilities
6200054 usd
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
975000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
975000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214631331 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214631331 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123106039 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123106039 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
214631 usd
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
123106 usd
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
558926 usd
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
467247 usd
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6114193 usd
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6758480 usd
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-5340298 usd
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-6167953 usd
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41602 usd
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32101 usd
CY2016 us-gaap Revenues
Revenues
146731 usd
CY2015 us-gaap Revenues
Revenues
173560 usd
CY2016 us-gaap Operating Expenses
OperatingExpenses
359634 usd
CY2015 us-gaap Operating Expenses
OperatingExpenses
831489 usd
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-212903 usd
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-657927 usd
CY2016 us-gaap Interest Expense
InterestExpense
335120 usd
CY2015 us-gaap Interest Expense
InterestExpense
290819 usd
CY2016 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1192310 usd
CY2015 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
222251 usd
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
857190 usd
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
513070 usd
CY2016 us-gaap Net Income Loss
NetIncomeLoss
644287 usd
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1170997 usd
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.004
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.001
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172312161 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63865281 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
671516358 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
452789678 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6991 usd
CY2015 QBAN Distributions
Distributions
-62135 usd
CY2015 QBAN Recapitalization Telco Cuba
RecapitalizationTelcoCuba
-5424766 usd
CY2015 QBAN Conversion Of Debentures
ConversionOfDebentures
17520 usd
CY2015 QBAN Issuance Of Common Shares As Payment For Consulting Services
IssuanceOfCommonSharesAsPaymentForConsultingServices
70717 usd
CY2015 QBAN Issuance Of Preferred C Shares
IssuanceOfPreferredCShares
394718 usd
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1170997 usd
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-6167953 usd
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
142500 usd
CY2015 QBAN Common Stock Issued For Merger And Recapitalization Net
CommonStockIssuedForMergerAndRecapitalizationNet
5470140 usd
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-6167953 usd
CY2016 QBAN Sale Of Common And Preferred Stock
SaleOfCommonAndPreferredStock
142500 usd
CY2016 QBAN Note Payable Conversion
NotePayableConversion
26394 usd
CY2016 QBAN Issuance Of Common Shares As Payment For Consulting Services
IssuanceOfCommonSharesAsPaymentForConsultingServices
14374 usd
CY2016 QBAN Issuance Of Preferred C Shares
IssuanceOfPreferredCShares
100 usd
CY2016 us-gaap Net Income Loss
NetIncomeLoss
644287 usd
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-5340298 usd
CY2016 us-gaap Net Income Loss
NetIncomeLoss
644287 usd
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1170997 usd
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1192311 usd
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-222252 usd
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
119366 usd
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60977 usd
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
14474 usd
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
465436 usd
CY2016 QBAN Depreciations
Depreciations
263 usd
CY2015 QBAN Depreciations
Depreciations
-13192 usd
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9508 usd
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
953 usd
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5450 usd
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64417 usd
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3453 usd
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
77290 usd
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
304833 usd
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-268156 usd
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128191 usd
CY2016 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
219728 usd
CY2015 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
335343 usd
CY2016 us-gaap Repayments Of Debt
RepaymentsOfDebt
80250 usd
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
149150 usd
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
62137 usd
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
281978 usd
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124056 usd
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13822 usd
CY2015 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4135 usd
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7592 usd
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11727 usd
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21414 usd
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7592 usd
CY2016 QBAN Preferred B Stock Conversion To Common Shares
PreferredBStockConversionToCommonShares
19000 usd
CY2015 QBAN Preferred B Stock Conversion To Common Shares
PreferredBStockConversionToCommonShares
61680 usd
CY2016 us-gaap Stock Issued1
StockIssued1
26394 usd
CY2015 us-gaap Stock Issued1
StockIssued1
17520 usd
CY2015 QBAN Transfer Insufficient Additional Paidincapital Balance To Retained Earnings
TransferInsufficientAdditionalPaidincapitalBalanceToRetainedEarnings
5532337 usd
CY2016 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_809_eus-gaap--NatureOfOperations_zS1JAuhOhiag" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zxLx8jfETLce">Nature of Operations and Going Concern</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telco Cuba, Inc. (fka CaerVision Global, Inc., fka American Mineral Group Minerals Inc.) (the “Company”) was incorporated in the State of Nevada on August 10, 2007. Up until June 12, 2015, the company was previously engaged in the exploration, development, and acquisition of mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 12, 2015, the Company consummated a Share Exchange with Amgentech, Inc., a Florida corporation. <span id="xdx_900_ecustom--SharesExchangeDescription_c20151201__20161130" title="Shares Exchange description">Under the terms of the Share Exchange, the holders of Amgentech received 50,088 shares of Series B Preferred Stock that had been previously issued to third parties in exchange for 100% of the issued and outstanding capital of Amgentech. Each share of Series B preferred is convertible into 5,000 shares of common stock (254,440,000 shares total) and has voting rights of 5,000 per share (254,440,000 votes).</span> As a result of this transaction, Amgentech became a wholly owned subsidiary of the Company with control transferring to the previous owners of Amgentech. Amgentech elected to be treated as the successor issuer for SEC reporting and accounting purposes. The Share Exchange was accounted for as a reverse acquisition and re-capitalization. The Amgentech Shareholders obtained approximately 60% of voting control on the date of Share Exchange. Amgentech was the acquirer for financial reporting purposes and the Company was the acquired company.   The Company filed an amendment to its articles of incorporation and changed its name to Telco Cuba, Inc. Telco Cuba is foremost a technology solutions service provider offering services under the brand names “Amgentech” and “Telco Cuba”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on the basis of accounting principles applicable to a going concern; accordingly, they do not give effect to adjustments that would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and retire its liabilities in other than the normal course of business and at amounts different from those in the accompanying financial statements. As shown in the accompanying financial statements, the Company has an accumulated deficit of more than $<span id="xdx_90C_eus-gaap--RetainedEarningsAppropriated_iI_pp0n3_dm_c20161130_zQLDOPHMwvz2" title="Accumulated deficit">5.7</span> million. The Company currently does not have the cash resources to meet its operating commitments for the next twelve months and expects to have ongoing requirements for capital investment or debt to implement its business plan. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern for a reasonable period of time. Management plans to raise cash from public or private debt or equity financing, on an as needed basis. The Company’s ability to continue as a going concern is in substantial doubt unless it can achieve profitable operations and/or upon obtaining additional financing. The outcome of these matters cannot be predicted at this time.</span></p>
CY2016 QBAN Shares Exchange Description
SharesExchangeDescription
Under the terms of the Share Exchange, the holders of Amgentech received 50,088 shares of Series B Preferred Stock that had been previously issued to third parties in exchange for 100% of the issued and outstanding capital of Amgentech. Each share of Series B preferred is convertible into 5,000 shares of common stock (254,440,000 shares total) and has voting rights of 5,000 per share (254,440,000 votes).
CY2016Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
5700000 usd
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172312161 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63865281 shares
CY2016 QBAN Convertible Debentures
ConvertibleDebentures
499204197 shares
CY2015 QBAN Convertible Debentures
ConvertibleDebentures
388924397 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
671516358 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
452789678 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
57525192 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
26394 usd
CY2016Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0003
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
132098 usd
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1324409 usd
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1324409 usd
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
921815 usd
CY2015 QBAN Derivative Liabilities Recorded
DerivativeLiabilitiesRecorded
180343 usd
CY2016 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1192311 usd
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
222251 usd
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
132098 usd
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1324409 usd
CY2016 QBAN Unrealized Gain Attributable Due To Change In Liabilities
UnrealizedGainAttributableDueToChangeInLiabilities
1192311 usd
CY2015 QBAN Unrealized Gain Attributable Due To Change In Liabilities
UnrealizedGainAttributableDueToChangeInLiabilities
222251 usd
CY2016 QBAN Net Unrealized Gain Loss Included In Earnings
NetUnrealizedGainLossIncludedInEarnings
-1192311 usd
CY2015 QBAN Net Unrealized Gain Loss Included In Earnings
NetUnrealizedGainLossIncludedInEarnings
-222251 usd
CY2016Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
5000000 shares
CY2016Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
14370 usd
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000 shares
CY2016Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000.00 usd
CY2015Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
60680000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zS4j5TaV6Tfa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zXrB1pXpJuMf">Estimates</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from those reported.</span></p>
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zwx8D87TCUxd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z4gLJp3p83Cf">Accounts receivable and concentration of credit risk</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides credit to its clients in the form of payment terms. The Company limits its credit risk by performing credit evaluations of its clients and maintaining a reserve, if deemed necessary, for potential credit losses. Such evaluations include the review of a customer’s outstanding balances with consideration towards such customer’s historical collection experience, as well as prevailing economic and market conditions and other factors. The Company currently has no accounts receivable in 2016 and, therefore, does not currently have a concentrated credit risk associated with trade receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/>
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6686 usd
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6423 usd
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14738 usd
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15001 usd
CY2016 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2015 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2016 us-gaap Depreciation
Depreciation
263 usd
CY2015 us-gaap Depreciation
Depreciation
13192 usd
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
975000000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
975000000 shares
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
225500 usd
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-409800 usd
CY2016 QBAN Utilization Increase In Tax Loss Carryforward
UtilizationIncreaseInTaxLossCarryforward
-225500 usd
CY2015 QBAN Utilization Increase In Tax Loss Carryforward
UtilizationIncreaseInTaxLossCarryforward
409800 usd
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7100000 usd
CY2016Q4 us-gaap Convertible Debt
ConvertibleDebt
572843 usd
CY2015Q4 us-gaap Convertible Debt
ConvertibleDebt
395479 usd
CY2016 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
499204917 shares
CY2015 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
388924397 shares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y3M
CY2016Q4 us-gaap Share Price
SharePrice
0.004
CY2015Q4 us-gaap Share Price
SharePrice
0.004
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
395479 usd
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
375925 usd
CY2016 QBAN Issuance Of New Convertible Notes
IssuanceOfNewConvertibleNotes
216642 usd
CY2015 QBAN Issuance Of New Convertible Notes
IssuanceOfNewConvertibleNotes
305343 usd
CY2015 QBAN Discount Upon Issuance Of New Notes
DiscountUponIssuanceOfNewNotes
-180343 usd
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
119366 usd
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60977 usd
CY2016 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
68250 usd
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
149150 usd
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
26394 usd
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
17273 usd
CY2016Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
636843 usd
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
395479 usd
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
41111 usd
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
27662 usd
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
64372 usd
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
69071 usd
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
140000 usd
CY2015 QBAN Initial Fair Value Of Embedded Debt Derivative
InitialFairValueOfEmbeddedDebtDerivative
180343 usd
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.5294 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.5294 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y3M
CY2016Q4 QBAN Due To Nonaffiliated Third Parties
DueToNonaffiliatedThirdParties
2233361 usd
CY2015Q4 QBAN Due To Nonaffiliated Third Parties
DueToNonaffiliatedThirdParties
2337938 usd
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
132577 usd
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
104577 usd
CY2015 QBAN Issuance Of Notes To Related Party
IssuanceOfNotesToRelatedParty
28000 usd
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12000 usd
CY2016Q4 us-gaap Notes Payable
NotesPayable
2353938 usd
CY2015Q4 us-gaap Notes Payable
NotesPayable
2365938 usd
CY2016 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
145669 usd
CY2015 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
168851 usd
CY2016Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
135577 usd
CY2015Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
134550 usd
CY2016 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.12 pure

Files In Submission

Name View Source Status
0001099910-22-000217-index-headers.html Edgar Link pending
0001099910-22-000217-index.html Edgar Link pending
0001099910-22-000217.txt Edgar Link pending
0001099910-22-000217-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qban-20161130.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
qban-20161130_cal.xml Edgar Link unprocessable
qban-20161130_def.xml Edgar Link unprocessable
qban-20161130_pre.xml Edgar Link unprocessable
qban-20161130_lab.xml Edgar Link unprocessable
Show.js Edgar Link pending
telcocuba_10k.htm Edgar Link pending
telcocuba_ex31.htm Edgar Link pending
telcocuba_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
telcocuba_10k_htm.xml Edgar Link completed